ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   
 Top Breaking News
 Monday, September 15, 2014




 Yesterday's Most Popular News 
Google Inc.-Backed Calico Announces Plan To Combat ALS, Parkinson's

Traders Wobble On Merck KGaA (MKGAF.PK) After Stimuvax Stop

Eli Lilly and Company (LLY)'s Cyramza Met Primary Endpoint In Phase 3 Study

Novo Nordisk A/S (NVO)'s Liraglutide Safe, Effective For Obesity: FDA Panel

Oxygen Biotherapeutics, Inc. (OXBT) Shares Gyrate After Halting Mid-Stage Brain Injury Trial

FDA Approves Orexigen Therapeutics, Inc. (OREX)'s Long-Awaited Weight Loss Drug Contrave

High Protein Diets Lead To Lower Blood Pressure, Boston University Medical Center Study Finds

AbbVie (ABBV)'s Phase 3 Trial Of Humira Meets Primary Endpoint

Can The Fatty Acid In Breast Milk Predict Test Scores? University of California, Santa Barbara And University of Pittsburgh Study

Sanofi (France) (SAN.PA)'s Genzyme Corporation (GENZ) Report Positive New Data From Lemtrada Multiple Sclerosis Trial


 
-

 Featured Stories
 
Sunny Skies Linked To Suicide Rates, Medical University of Vienna Study
Honesty Linked To The Prefrontal Region Of The Brain, University of California, Berkeley (CAL) Study
Inflammation May Be Key To Diabetes/Heart Disease Link, Universidad Autónoma de Madrid Study
Neural Compensation Found In People With Alzheimer’s-Related Protein, University of California, Berkeley (CAL) Study
Botox "May Stunt Emotional Growth" In Young People, Aesthetic Nursing Reveals
Sleep Doesn't Stop The Brain: Words Are Still Being Classified, Ecole Normale Supérieure Study
High Protein Diets Lead To Lower Blood Pressure, Boston University Medical Center Study Finds
Can The Fatty Acid In Breast Milk Predict Test Scores? University of California, Santa Barbara And University of Pittsburgh Study
More Featured Stories

  Today's Top Jobs

 Featured Employer
About Genzyme Genzyme is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before. Genzyme has pioneered the development and delivery of transformative therapies for over 30 years. Founded in 1981 in Boston, Massachusetts, Genzyme evolved from a tiny start-up with just a handful of employees to one of the world's leading biotech companies. Acquired by Sanofi in 2011, Genzyme now benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients. Genzyme has long been known for our expertise in the class of rare genetic diseases known as lysosomal storage disorders (LSDs). LSDs remain the heart of our company today, but we have also expanded – through both in-house development and strategic acquisitions and partnerships – to other disease areas such as thyroid cancer and multiple sclerosis. Learn more at www.jobsatgenzyme.com. Follow our jobs on Twitter www.twitter.com/genzymejobs. Follow us on LinkedIn http://www.linkedin.com/company/genzyme. About Sanofi Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets, and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Show me jobs for this employer

 Careers
 
More Career Tips